← Leaderboards
Jill Gilbert
Louisiana State Univ Hsc New Orleans
$734,194
Attributed
$734,194
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263.7K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$734,194 · 14
By mechanism
P20$398,896 · 2
U10$211,735 · 1
M01$123,563 · 11
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ Hsc New Orleans
Same institution · by research overlap
- Robert W Veith$6,199,091
- Alfredo Lopez-S$495,062
- Augusto C Ochoa$52,418,882
- Pelayo Correa$2,775,322
- Jack P Strong$1,804,288
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationPatient Oriented ResearchClinical ResearchNeoplasm /Cancer Radiation TherapyHead /Neck NeoplasmCombination Cancer TherapySquamous Cell CarcinomaNeoplasm /Cancer ChemotherapyClinical TrialsCommunity Health ServicesCooperative StudyData ManagementDisease /Disorder ModelDrug Screening /EvaluationEarly DiagnosisEnzyme Induction /RepressionHealth Services Research TagLaboratory MouseMass ScreeningMedical Outreach /Case FindingMedical Rehabilitation Related TagMentoring /MentorNeoplasm /Cancer Diagnosis
Grant awards (16)
LSUHSC COBRE: PROJ 1: TOLERANCE MECHANISMS IN HEAD & NECK CANCER$197,595
P20 · FY2006 · RR · contact PI
STUDY OF OSI-774 IN COMBINATION WITH RADIATION THERAPY IN ORAL CAVITY CANCER$17,096
M01 · FY2006 · RR · contact PI
STUDY OF STANDARD DOXORUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST CANCER$8,354
M01 · FY2006 · RR · contact PI
PHASE III TRIAL OF CONCURRENT RADIATION AND CHEMOTHERAPY FOR HEAD/NECK CANCER$5,440
M01 · FY2006 · RR · contact PI
CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR ADVANCED SQUAMOUS CELL CARCINOMA$194
M01 · FY2006 · RR · contact PI
STUDY OF BMS-247550 IN PATIENTS WITH CANCER OF THE HEAD AND NECK$194
M01 · FY2006 · RR · contact PI
LSUHSC COBRE: PROJ 1: TOLERANCE MECHANISMS IN SCCHN$201,301
P20 · FY2005 · RR
PHASE III TRIAL OF CONCURRENT RADIATION AND CHEMOTHERAPY FOR HEAD/NECK CANCER$53,099
M01 · FY2005 · RR
STUDY OF STANDARD DOXORUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST CANCER$2,662
M01 · FY2005 · RR
A CLINICAL TRIAL COMPARING THREE COMBINATIONS OF CHEMOTHERAPY IN BREAST CANCER$1,775
M01 · FY2005 · RR
STUDY OF OSI-774 IN COMBINATION WITH RADIATION THERAPY IN ORAL CAVITY CANCER$1,775
M01 · FY2005 · RR
PHASE II TRIAL OF WEEKLY IRINOTECAN AND DOCETAXEL IN RECURRENT HEAD/NECK CANCER$1,627
M01 · FY2005 · RR
TRIAL OF CISPLATIN/ETOPOSIDE/RADIOTHERAPY IN PATIENTS WITH INOPERABLE NSCLC$1,479
M01 · FY2005 · RR
Study of OSI-774 in Combination With Radiation Therapy$29,514
M01 · FY2004 · RR
Phase III Trial of Concurrent Radiation and Chemotherapy for Head/Neck Cancer$354
M01 · FY2004 · RR
LSUHSC Minority Based Community Clinical Oncology$211,735
U10 · FY2002 · CA